Interleukin-12 (IL-12) induces differentiation of T helper 1 (Thl) cells, primarily through its ability to prime T cells for high interferon-~/ (IFN-~) production. We now report that the presence of IL-12 during the first several days of in vitro clonal expansion in bruiting dilution cultures of polyclonally stimulated human peripheral blood CD4 + and CD8 + T cells also induces stable priming for high IL-10 production. This effect was demonstrated with T cells from both healthy donors and HIV(+) patients. Priming for IL-4 production, which requires IL-4, was maximum in cultures containing both IL-12 and IL-4. IL-4 modestly inhibited the IL-12-induced priming for IFN-% but almost completely suppressed the priming for IL-10 production. A proportion of the clones generated from memory CD45RO + cells, but not those generated from naive CD451KO-CD4 + T cells, produced some combinations of IFN-% IL-10, and IL-4 even in the absence of IL-12 and IL-4, suggesting in vivo cytokine priming; virtually all CD4 § clones generated from either CD45RO(-) or (+) cells, however, produced high levels of both IFN-~/and IL-10 when IL-12 was present during expansion. These results indicate that each Thl-type (IFN-~/) and Th2-type (IL-4 and IL-10) cytokine gene is independently regulated in human T cells and that the dichotomy between T cells with the cytokine production pattern of Thl and Th2 cells is not due to a direct differentiation-inducing effect of immunoregulatory cytokines, but rather to secondary selective mechanisms. Particular combinations ofcytokines induce a predominant generation ofT cell clones with anomalous patterns of cytokine production (e.g., IFN-~ and IL-4 or IFN-~/ and IL-10) that can also be found in a proportion of fresh peripheral blood T cells with "memory" phenotype or clones generated from them and that may identify novel Th subsets with iminunoregulatory functions.
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T
he immune response to infectious agents and to nominal antigens is often characterized by a dominance of either cell-mediated or humoral-type effector mechanisms (1) , which has been attributed to a dichotomy in the cytokine production pattern of T helper (Th) CD4 + cells (2) . Two classes of Th cells have been described: Thl cells, which produce interleukin-2 (IL-2), interferon-~/(IFN-~/) and lymphotoxin (LT) and favor cell-mediated immunity, delayedtype hypersensitivity, macrophage activation, and produc6on of opsonizing antibodies; and Th2 cells, which produce IL-4, IL-5, IL-6, IL-10, and favor humoral responses, production of IgE and IgA, and activation of eosinophils and basophils. The differentiation of Th cells toward a Thl or Th2 phenotype occurs early during an immune response Drs. Gerosa and Paganin contributed equally to this work. and is influenced by many interrelated factors, including the nature and the concentration of the antigen, the anatomical locahzation of the immune response, the nature of the antigen-presenting cells (APC), and the cytokine milieu at the site of the immune response (3) . IL-4, produced by T cell subsets and possibly basophils, appears to be the most important cytokine responsible for Th2 cell generation (4), whereas IL-12, produced by macrophages and professional APC such as dendritic cells and Langerhans cells (5) (6) (7) (8) , is required for effective Thl cell generation (9) (10) (11) (12) . IL-12 acts at three different levels in favoring a Thl response: (a) it acts as a proinflammatory cytokine inducing IFN-~/from T and NK cells within a few hours after infection, and through IFN-~/ it induces activation of phagocytic cells for bacteriocidal activity and also for enhanced production of cytokines, including IL-12 itself (6, 13-15); (b) in the first few days of an immune response, IL-12 and IL-12-induced IFN-~/act on antigen-stimulated T cells to favor differentiation and proliferation of cells with a Thl phenotype (9--12) ; (c) once differentiated Thl are generated, IL-12 is required for optimal cytokine production and, in certain cases, proliferation of Thl cells (16) . One of the central mechanisms by which IL-12 induces differentiation of Thl cells is its ability to prime T cells during clonal expansion for high IFN-'y production (17) (18) (19) . This priming effect oflL-12 is stable, and T cell clones originally expanded in the presence of IL-12 maintain the ability to produce high IFN-~/levels upon restimulation even when cultured for at least several weeks in vitro in the absence of IL-12 (17) . However, IL-12 when present during restimulation also enhances IFN-~/ production from established Thl clones (16, 17) and transiently induces low level IFN-",/ production from established Th2 clones (17, 20) . Like CD4 + T cells, CD8 + T cells also display either a Thl or Th2 phenotype (17, 21, 22) , and IL-12 induces a priming for high IFN-',/production in both CD4 + and CD8 + T cells (17, 18) .
Although the expression of Thl-type and Th2-type cytokines was initially considered to be mutually exclusive, Th cells expressing both Thl and Th2 cytokines (referred to as Th0 cells) have been identified both during differentiation of Th cells (23) and in terminally differentiated cells (24) . Indeed, evidence for a stochastic acquisition of cytokine profile, suggesting independent regulation of each cytokine gene, was obtained during a mouse Th2 response to keyhole limpet hemocyanin (KLH) (25) and in human peripheral blood memory CD4 + T cells (26, 27) . Our findings that IL-12 has a potent priming effect on human T cells for high IFN-3~ production, but no direct effect on IL-4 production by T cell clones, also strongly suggested an independent regulation of IFN-~/ and IL-4 gene expression (17) . IL-10, like IL-4, was thought to be produced exclusively by Th2 cells in the mouse (2) , but it has since been reported that both mouse and human IL-10-producing cells can coexpress either IL-4 or IFN-~/ (28, 29) .
In this paper, we analyzed the effect oflL-12 on the expression oflL-10 in human CD4 + and CD8 + T cell clones. We find that IL-12 when present in the limiting dilution cultures in the first few days of clonal expansion, primes CD4 + and CD8 + T cell clones for high production of both IFN-~/and IL-10. IL-12 does not prime for IL-4 production, which requires the presence of IL-4 during clonal expansion; however, priming for IL-4 production is maximal in cultures containing both IL-12 and IL-4. IL-4 has a modest inhibitory effect on the IL-12-induced priming for IFN-~/ production, but almost completely suppresses the priming for IL-10 production.
Materials and Methods
Reagents. Phytohemagglufinin (PHA) was purchased from Grand Island Biological Co. (Grand Island, NY). Dermatophagoides pteronyssinus group I (Der p I) was kindly provided from Lofarma A1-lergeni (Milan, Italy), and 12-0-tetradecanoyl-phorbol-13-acetate (TPA) I was from Sigma Chemical Co. (St. Louis, MO). Anti-CD3, anti-CD4, and anti-CD8 mAbs were purchased from Ortho Pharmaceuticals (R.aritan, NJ) and Becton-Dickinson (Mountain View, CA), or produced from cells obtained from American Type Culture Collection (ATCC, tkockville, MD). Human recombinant IL-2 (rIL-2) was a gift of Eurocetus (Milan, Italy) and of Dr. T. Taguchi (Osaka University, Osaka, Japan). Human rlL-12 (CHOcell derived) was provided by Dr. Stan Wolf (Genetics Institute Inc., Cambridge, MA). Human rIL-4 was purchased from Genzyme (Cambridge, MA) and had a specific activity of 107 U/mg. Human rIFN-'y (7 • 107 U/mg) was provided by Dr. H.M. Shepard (Genentech Inc., South San Francisco, CA).
Subjects. Peripheral blood mononuclear cells (PBMC) were obtained by Ficoll-Hypaque gradient separation from peripheral blood of healthy volunteers and human immunodeficiency virus type 1 (HIV-1)-infected individuals, recruited from the Immunodeficiency Program of the Hospital of the University of Pennsylvania. CD4 + lymphocyte counts were obtained on the same day that patients' blood was obtained for use in this study. Patients were categorized according to the Centers for Disease Control criteria on the basis of CD4 + lymphocyte number and HIVrelated symptomatology and complications (30) .
Generation of CD4 + and CD8 + T Cell Clones. T cell clones were generated from PBMC by limiting dilution (17, 31) . 0.5 PBMC/well were seeded in 96-well round-bottom tissue culture plates in 200 p,1 of RPMI-1640 medium with 10% FCS in the presence of 5 p,g/ml PHA, "y-irradiated (50 Gy) autologous (for cloning of healthy donor T cells) or allogeneic (for cloning of HIV(+) patients' T cells) PBMC (2.5 X 104 cell/well) and P,.PMI-8866 B lymphoblastoid cells (104 cells/well) in the presence of IL-12 (2.5 ng/ml), IL-4 (50 U/ml), neutralizing anti-IL-12 mAb C8.6 (ascites, 1:400, sufficient to completely neutralize more than 10 ng/ml of IL-I2, a level higher than that possibly produced by the feeder cells) (6), anti-IL-4 neutralizing antibodies 4F2 and 5A4 (32), a combination of cytokines and antibodies or culture medium. In some experiments, limiting dilution cloning was performed in U-bottom plates coated with anti-CD3 mAb (OKT3, 5 p,g/ml in carbonate buffer, pH 9.5) instead of in the presence of PHA. After 3 days, IL-2 (50 U/ml, final concentration) was added to all cultures by replenishing half of the medium. After 1 wk, irradiated PBMC (5 • 103/well) and RPMI-8866 (104/well) as feeder cells were added again; cells were maintained in culture with IL-2 and fed and split as required with the original combination of antibodies and/or cytokines maintained through the culture period, unless otherwise indicated. Cloning efficiency was calculated for CD4 + or CD8 + by Poisson distribution as described (17, 31, 33) ; only wells containing a sufficient T cell number to allow determination of both surface phenotype and cytokine profile were considered positive, The proportion of CD4 + and CD8 + T cells in the plated PBMC was taken into account in calculating the number of cells from either subset plated per well.
Surface Phenotype of T Cells. The phenotype of PBMC and T cell clones was examined by immunofluorescence (flow cytometry) using FITC-conjugated anti-CD3, anti-CD4, and anti-CD8 rnAbs as described (17) .
Sorting of CD45RO + and RO-T Cells. PBMC were stained by indirect immunofluorescence using the anti-CD45RO mAb Leu 45R.O (Becton Dickinson) and FITC goat anti-mouse Ig (Becton Dickinson). Cells were sorted using a Coulter Elite cell sorter (Hialeah, FL). Before sorting, 37% of lymphocytes were CD45R.O +. After sorting, purified CD45RO-cells were contaminated with 1.2% CD45RO + ceils and purified CD45R_O + cells were contaminated with 2% CD45RO-cells. Immediately after sorting, T cells were cloned by limiting dilution, as described above.
Induction of Cytokine Production by T Cell Clones. To induce cytokine production, T cell clones were resuspended in complete medium to a concentration of approximately 106/ml and stimulated for 24 h with soluble anti-CD3 mAb (OKT3, ascites 1:10,000) and TPA (10 ng/ml). Cell-free culture supematants were collected and stored in aliquots at -70~ until used.
Quantitation of lFN-% IL-4, and IL-I O. IFN-"/ was quantitated in T cell clone supernatants by radioimmunoassay (RIA) using mAbs B133.1 and B133.5 (34); IL-4 was quantitated by RIA using antibodies 4F2 and 5A4 (32) , kindly provided by Dr. Lucien Aarden (Central Laboratory of the Netherlands Red Cross, Amsterdam); IL-10 was quantitated by RIA using antibodies JE53 9D7 and 12G8, kindly provided by Dr. Anne O'Garra (DNAX, Palo Alto, CA). Recombinant human IFN-% IL-4, and IL-10 were used as reference standards.
Statistical Analysis. The statistical significance for the difference in cytokine production by the group of clones cultured in the different conditions was evaluated by student's t test; significant and not significant, when not specifically indicated, refer to P <0.05 and P >0.05, respectively.
Results

IL-12 Primes CD4 + and CD8 + Clones for IL-10 Production and IL-4 Inhibits Such Priming.
Freshly isolated peripheral blood lymphocytes (PBL) from two donors were cloned by limiting dilution in the presence of feeder cells, IL-2, and PHA or anti-CD3 antibodies bound to plastic. IL-12 and/or IL-4 was also added to some of the plates. When IL-12 or IL-4 was not added, the respective neutralizing antibodies were added to block endogenous cytokines. After 4 wk of culture, clones were washed, stimulated with soluble anti-CD3 antibodies and TPA for 18 h, and cytokine production in the supematant was evaluated by ILIA ( Fig. 1) . As previously reported (17) (18) (19) , the presence of IL-12 during cloning induced a several-fold increase in the ability of both CD4 § and CD8 + clones to produce IFN-~/, whereas it had a little and non-significant effect on IL-4 production. The addition of IL-4, either alone or with IL-12, had no significant effect on the production of IL-4, but partially inhibited the priming for IFN-'y production (Fig. 1) . The failure in these experiments to identify a requirement for IL-4 in the generation of IL-4 producing cells was likely due to the presence within the unfractionated PBL or memory T cells which, as described below, generate clones with high and variable ability to produce IL-4 even when expanded in the absence of IL-4. In addition to priming the T cell clones for IFN-~/production, IL-12, present during cloning, also primed them for high IL-10 production, an effect observed in both cloning conditions (PHA or anti-CD3) and with both CD4 + and CD8 § clones (Fig. 1) . IL-4 alone had no significant effect on the abihty of the clones to produce IL-10, but significantly and almost completely inhibited the priming effect oflL-12 on IL-10 production. Gerosa et al.
The ability of IL-12 or anti-IL-12 antibodies present during bruiting dilution cloning to prime CD4 + and CD8 + clones for IL-10 production was also observed in PBL from five other healthy individuals and 10 HIV(+) patients at various stages of the disease; analysis of all CD4 + and all CD8 + clones from either healthy donors ( Fig. 2 A) or HIV(+) patients ( Fig. 2 B) revealed significant IL-10 production after IL-12 priming (P = 0.027 for CD4 + cells from HIV(+) patients; P ~0.001 in all other groups). In several of the experiments represented in Fig. 2 , IL-12 was present only during the first 2 wk of the 4-wk cloning period.
Clones Derived from Naive and Memory CD4 + T Cells Are Differentially Affected by IL-12. Because of the high variability in cytokine production by clones derived from total PBL, even when cultured in the absence of added cytokines, we separately cloned CD4 § cells with a memory (CD45RO +) or naive phenotype (CD45tLO-) (35) (Figs. 3 and 4) . The large majority of CD4 + clones generated from CD45RO-cells in the presence of neutralizing antibodies to IL-12 and IL-4 produced negligible amounts oflFN-% IL-10, or IL-4 (Fig. 4) . By contrast, approximately half of the clones derived from CD45RO + cells produced IFN-~/ and IL-10, even when expanded in the presence of anti-IL-12 antibodies, and IL-4 even when expanded in the presence of anti-IL-4 (Fig. 3) . When cultured in the presence oflL-12, all clones produced high levels of IFN-~/ and IL-10, and when cultured in the presence of IL-4, most although not all the clones produced high levels of IL-4. However, the differential ability of the clones to produce the various cytokines depending on the culture conditions was much more obvious in the clones derived from CD45RO-cells (Figs. 3 and 4) . These clones expanded in the presence of anti-IL-12 produced very low levels of IFN-~/ or IL-10, which on average were increased 125-fold and 29-fold, respectively, in the clones expanded in the presence of IL-12. The production of IL-10 by the different clones was more variable than that of IFN-% as clearly shown by the SE in Fig. 4 . Thus, whereas IL-12 was an absolute requirement for high production of IFN-% a minor proportion of clones produced moderate to high IL-10 even when cultured in the absence of IL-12. IL-4 was required for priming CD45RO-cells for IL-4 production, but endogenously produced IL-4 in the cultures (most likely by the irradiated feeder cells) was sufficient, because addition of neutralizing antibodies to IL-4 to the cultures blocked IL-4 production by the clones, whereas addition of exogenous IL-4 only modestly increased IL-4 production as compared to that by clones generated without either IL-4 or anti-IL-4 antibodies (Fig. 4) . Interestingly, the highest production of IL-4 was reproducibly observed in clones generated in the presence of both IL-12 and IL-4, although all these clones also produced high levels of IFN-% In the presence of added IL-4, but not IL-12, approximately a quarter of the clones have a Th2 phenotype (i.e., they produced moderate to high amounts of both IL-4 and IL-10, but not IFN-~/). The presence oflL-4 during the expansion of the clones, as with total PBL cloning ( Fig. 1) , modestly decreased the priming effect of IL-12 for IFN-~/ production, but almost completely suppressed the IL-12 priming effect for IL-10 production (Fig. 4) .
The Priming Effect of lL-12 for IL-10 and IFN-y Production Is Not Mediated by IFN-T.
We investigated whether IFN-"/ induced by IL-12 plays a role in the priming of the T cell clones for IFN-3' and IL-10 production and whether IFN-y could replace IL-12 in inducing such a priming. As shown in Table 1 , neutralizing anti-IFN-'/antibodies did not prevent the IL-12-induced priming for IFN-3, production in clones originated from either CD4 + CD45RO-or CD8 + CD45RO-T cells, and exogenous recombinant IFN-y added to the cultures in the absence oflL-12, could not induce priming. In the case of priming for IL-10 production, anti-IFN-y antibodies partially but significantly (P <0.05) decreased it in CD4 + T cell clones, but have no effect in CD8 + T cell clones; in both types of clones, IFN-y could not replace IL-12 to induce IL-10 priming. No significant difference was observed in all these experimental conditions for IL-4 production by the clones. addition of neutralizing anti-IL-12 antibodies after 1 wk of limiting dilution culture in the presence of IL-12 only partially decreased and after 2 wk did not affect the priming for both IFN-~ and IL-10 production (results not shown).
The Priming Effect of I L-12for IL-10 Production Is Stable and Occurs in the First
To determine when during clonal expansion IL-12 induces priming for IFN-~/ and IL-10 production, low levels of neutralizing anti-IL-12 antibodies were added at the time of limiting dilution to prevent the effect of endogenously produced IL-12, and IL-12 at concentrations able to overcome the effect of the neutralizing antibodies was added at different times of culture. The priming effect was observed when IL-12 was added at day 0 or 3, but not when added at day 7 or later ( Fig. 5) .
Discussion
Accumulating evidence from in vivo and in vitro experimental systems supports the conclusion that IL-12 not only promotes Thl-type immune responses, but is also required in vivo for optimal Thl responses (8) (9) (10) 36) . In all these experimental systems, IL-12 not only induced an increase in IFN-~/ production, but also very efficiently suppressed the production of IL-4. However, the in vivo studies or the in vitro analysis based on the effect of IL-12 on bulk polyclonal T cell cultures did not distinguish between a direct effect of IL-12 on the differentiation of the Th clones, or an indirect effect favoring preferential expansion of Thl cells or inhibition of Th2 cell growth. To distinguish between direct effects on Th cell differentiation and selective effects, we (17) analyzed the effect of IL-12 on the cytokine production of human CD4 § and CD8 + T cells in a limiting dilution cloning system which allows the clonal expansion of almost every single T cell from peripheral blood. Because of the high clonal efficiency and the seeding of less than one cell per well, this experimental system allowed us to test direct differentiative effects of IL-12 at the clonaltevel. Whereas IL-12 induced a powerful priming for high IFN-~/production in every single clone analyzed, it had no significant effect on the ability of the clones to produce IL-4 (17). Thus, it was concluded that the priming for high IFN-~/production is a direct differentiation-inducing effect of IL-12, while the inhibition of IL-4 production may involve preferential expansion of Thl cells, due perhaps to the lack of functional IL-12 receptors on Th2 cells (37, 38) , or a selective growth inhibition of Th2 cells by IFN-~/(39), most likely due to the downmodulation of the IFN-~/receptor 13 chain in Thl cells (38, 40) .
There is relatively little information on the effect oflL-12 on T cell production oflL-10, but studies with bulk T cell cultures from atopic patients stimulated in vitro with allergen have shown that production of both Th2 cytokines, IL-4 and IL-10, is inhibited if lL-12 is added to the cultures (41). We have been able to reproduce these results both in bulk cultures or analyzing antigen-specific clones derived from these cultures (our unpublished results). However, in vivo treatment with IL-12 has been reported to result in a dramatic increase in both IFN-~/mRNA and IL-10 mRNA Our present data show that the presence of IL-12 in vitro during limiting dilution cloning of human CD4 + or CD8 + T cells results in an efficient priming of the clones for high production of both IFN-y and IL-10. This result was observed with both anti-CD3 or PHA stimulation and with PBL from both healthy donors and HIV(+) patients, from early to very advanced stages of HIV disease. These findings are consistent with the observation that T cells from HIV patients are fully responsive to IL-12 (18, 43, 44) , although their phagocytic cells and APC might be defective in IL-12 production (45, 46) .
The high variability in production of cytokines observed in human CD4 + T cell clones expanded in the absence of exogenous IL-12 and IL-4 or in the presence of neutralizing antibodies against these two cytokines suggests that some of the ceils were already primed in vivo for cytokine production. The cloning of sorted CD45R.O-naive CD4 + cells and CD45RO + memory CD4 + cells supported this interpretation. A high proportion of the clones generated in the presence of neutralizing antibodies to IL-12 and IL-4 produced one or a combination of IFN-',/, IL-4 and IL-10, with a pattern of production that was not always consistent with the classical paradigm of Thl and Th2 cells. When CD45P,.O-cells were cloned in the same conditions, the clones produced only negligible amounts of the three cytokines. However, in both populations, the presence of IL-12 during cloning endowed virtually all clones with the ability to produce high levels of IFN-y and IL-10. These data confirm our previous observations that IL-12 can induce a high IFN-y-producing Thl phenotype not only in naive T cells, but also in memory T cells, in response to either polyclonal activation or specific recall antigens (9, 17) . Surprisingly, the same observation held true for the priming of IL-10 production in a limiting dilution condition. Added IL-4 or endogenously produced IL-4 was necessary in the limiting dilution culture to prime T cell clones generated from CD45RO-cells for IL-4 production, whereas approximately half of the clones generated from CD45RO + cells produced IL-4 even when expanded in the absence of IL-4. Because of this high variability in IL-4 production in memory T cells, the requirement for IL-4 in the generation lL-2-induced Priming for IL-10 Production of IL-4 producing cells could not be demonstrated in CD4 + CD45RO + cells (Fig. 3) or unfractionated PBL (Fig. 1) . Although IL-12 is a major and probably necessary inducer of a Thl response, in several experimental conditions, it also potentiated IL-4 production and the development of Th2 cells from naive CD4 + murine T cells (47) and from neonatal CD4 + human T cells (48) , and potentiated a Th2 response to Schistosoma mansoni in IFN-',/ knockout mice (49) . Our present data show that IL-12 does not prevent IL-4 production from CD4 + clones derived from limiting dilutions of naive adult peripheral blood CD45RO-cells and, in fact, significantly enhances the ability of IL-4 to prime the clones for high IL-4 production, thus extending the previously published results (47) (48) (49) by demonstrating that IL-12 enhances IL-4 production at the single clonal level via a differentiation effect. Furthermore, when T cells were cloned in the simultaneous presence oflL-12 and IL-4, the IFN-"/ priming effect of IL-12 was only partially and often not significantly inhibited by IL-4, whereas the priming for IL-10 production was reproducibly and almost completely blocked by IL-4. Thus, paradoxically, IL-4 is more potent in inhibiting priming of Th cells for production of a Th2-type cytokine than for the typical Thl-type cytokine, IFN-'y.
Several authors have reported the requirement of IFN-~/ production for the induction of Thl response in vivo and in vitro (11, (49) (50) (51) (52) ; however, this role for IFN-~/was not confirmed in other murine studies (53, 54) and in none of the human studies (9, 41, 48) . In the present study, neutralizing anti-IFN-~/ antibodies did not prevent the IL-12-induced priming for IFN-~ production and only partially decreased priming for IL-10 in CD4 + but not in CD8 + clones. Recombinant IFN-~/could not replace IL-12 in the priming for either IFN-~ or IL-10 production.
We have previously shown that the priming for high IFN-~/-induced production induced by IL-12 is stable and that if IL-12 is present in the first 2 wk of culture, the clones can be cultured for at least 3 more weeks in the absence of IL-12 and maintain their ability to produce high levels of IFN-"/ (17, 18) . For induction of IFN-~/production in the clones, IL-12 needs not be present during stim- ulation with various IFN-~ inducers; however, when present, it increases IFN-'y production, both in IFN-~ producer clones and, at lower levels, in non-IFN-~/ producer Th2 clones (17, 20) . We now find that the priming for high IL-10 production induced by IL-12 has very similar characteristics to that of IFN-~/ production and that IL-10 priming is induced when IL-12 is present in the limiting dilution culture in the first 1 or 2 wk and is maintained when cells are cultured in the absence of IL-12. As with IFN-% the presence of IL-12 is not required during stimulation of the clones for IL-10 production, but its presence enhances IL-10 production. The time of addition of IL-12 to the limiting dilution cultures is also critical: if IL-12 is added at day 0 or 3, priming for both IFN-'y and IL-10 is observed; however, if added at day 7 or later, almost no priming effect is observed. These results suggest that the clones are susceptible to the priming effect of IL-12 in a very narrow temporal window during the first few days of clonal expansion. IL-12 primes T cells for IFN-y and IL-10 production in a similar fashion, but its ability to induce acute expression of either cytokine is quite different. In freshly isolated PBL, IL-12 alone induces IFN-y production and synergizes with many other stimuli (14) , whereas in the same conditions, no induction of IL-10 is observed, although a more detailed analysis of different stimulatory conditions remains to be performed. However, a few days of culture of PBL stimulated with PHA or anti-CD3 in the presence oflL-12 results in high constitutive expression of IL-10, and IL-12 strongly potentiates the acute production of IL-10 observed in CD4 § and CD8 § T cell clones stimulated with anti-CD3 antibodies (D. Peritt and G. Trinchieri, manuscript in preparation). Although the mechanism of this priming remains elusive, it is clearly distinct from that responsible for acute IFN-',/and IL-10 production, which is still effective on advanced or terminally differentiated Thl and Th2 clones (17, 20) , and is reminiscent of the commitment to a Thl or Th2 response in vivo that is observed within a few days after immunization (11, 25) .
In conclusion, our present results and previous reports indicate that IL-12 induces priming for high IFN-y (17) and IL-10 production (this article). We also confirm in our clonal assay with human T ceils that IL-4 is required for IL-4 production priming (4). IL-12 and IL-4 modulate each other's effect, i.e., IL-4 acting at the clonal level partially decreases the priming for high IFN-y production induced by IL-12 and very efficiendy prevents the priming for IL-10 production. At the clonal level, the ability of IL-12 to inhibit IL-4 production, a striking phenomenon in vivo or in polyclonal cultures, is not observed and instead IL-12 enhances the ability of IL-4 to prime for IL-4 production. Thus, similar to recent observations in the mouse system (25, 55) , our results suggest that the IFN-% IL-4, and IL-10 cytokine genes are independently regulated and that any combination of these three cytokines can be observed in clones generated from human peripheral blood without a clear distinction along the Thl or Th2 phenotype, even when the priming effect of IL-12 or IL-4 in vitro is neutralized using specific antibodies. However, when antigen-specific clones are generated in vivo or in vitro in polyclonal cultures, a preferential clustering of Thl or Th2-type cytokines is observed, both at the polyclonal and the clonal level. Because IL-12 and IL-4 do not induce this dichotomy at the single cell (or clonal) level in vitro, it is likely that the mechanisms leading to the Thl/Th2 polarization involve secondary induced factors and/or selective mechanisms, which may be influenced by the nature and concentration of the antigen, the APC, and other cytokines present at the site of the immune response. However, it is striking that many of the clones obtained from memory human T cells cultured in the absence of IL-12 and IL-4 (a condition that does not endow naive CD4 cells with the ability to produce cytokines) can produce high levels of one or more of the cytokines IFN-',/, IL-4, and IL-10. The pattern of production of these three cytokines appears to be stochastic, with no clear polarization of the cells to a Thl or Th2-type phenotype. Similarly, coexpression of IFN-2t and IL-4 was described in a proportion of memory CD4 + T cells with the CD45RO + or CD27--phenotype (26, 27) . Because CD4 + T cells in those studies were analyzed immediately after purification from peripheral blood, possible artifacts due to the long-term cloning cultures were excluded. Note that like the studies analyzing cytokine production in fleshly isolated CD4 + peripheral blood when actively stimulated (26, 27) , our work shows that clones generated from CD4 + CD45RO-cells in the absence of IL-12 or IL-4 are unable to produce cytokines, whereas clones generated from CD4 + CD45RO + cells produce cytokines with a pattern reflecting that of freshly isolated CD45RO + cells. The cloning procedure in the presence of both IL-2 and a polyclonal stimulator, such as PHA, does not alter the cytokine profile of the CD4 + cells, thus representing a powerful method to study the role of cytokines such as IL-12 during clonal expansion in determining the cytokine profile of responding CD4 + T cells.
The Th2 cytokine IL-10 has a profound inhibitory effect on the ability of phagocytic cells to produce IL-12 (56) , and this effect may represent one of the mechanisms by which a Thl response is downregulated when Th2-type cells are activated. However, this simple interpretation is now complicated by the observation that CD4 + cells producing both IFN-~/ and IL-10 exist in humans and in the mouse (28, 29) , and can easily be cloned from peripheral blood T cells (this study and 57). Human T cell clones producing IFN-~/ and IL-10 have an anti-inflammatory function, inhibiting macrophage activation and T cell proliferation (57) , and can be isolated with high frequency from T cell populations within the rheumatoid synovial membrane (58) , where they may be a major contributor to the endogenous immunosuppression that occurs in rheumatoid arthritis. Notably high IFN-'y-and IL-10-producing clones are induced by stimulation with an antigenic peptide of proteolipoprotein, which is mutated in the major TCRinteracting residue and which protects mice from allergic encephahtis induced by the wild-type peptide; these IFN-',/-and IL-10-producing clones have an anti-encephalitogenic effect in vivo, suggesting that they might represent cell types involved in the downregulation of Thl responses (59) . The CD4 + cell types with unusual cytokine production profiles may represent new subsets of Th cells, with effector functions different from the typical Thl and Th2 cells and mediating different effects on specific aspects of humoral and/or cellular immune response. An alternative interpretation is that successful immune responses are characterized by a polarized Thl or Th2 response, whereas ineffective responses resulting in anergy or tolerization may be characterized by anomalous cytokine production phenotypes that fall to sustain an effective cellular or humoral immune response. The accumulation of these cell types in the memory compartment of peripheral blood CD4 + cells may represent the end product of unsuccessful or repressed immune responses. In particular, the extreme phenotype of high IFN-~/and IL-10 production induced by IL-12 may represent a cell type with a downregulatory effect on Thl responses, by suppressing expression of IL-12, TNF-ci, IL-113, B7, and other costimulatory molecules on APC as well as proliferation of Thl cells (56, 60) .
